Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHD.L Regulatory News (PHD)

  • There is currently no data for PHD

Board Appointment

30 Sep 2008 07:00

RNS Number : 6289E
PROACTIS Holdings PLC
30 September 2008
 



PROACTIS Holdings PLC

("PROACTIS", "the Group" or "the Company")

Board Appointment

PROACTIS Holdings PLC (AIM: PHD), the specialist Spend Control software company, is pleased to announce the appointment of Mark McCarthy to the Board as an Executive Director with effect from 30 September 2008.

Mark James McCarthy, age 32, was one of the founding employees of PROACTIS in 1996, when he was responsible for marketing. In this role Mark developed the "spend control" brand and established the Group's successful channel partner programme, before leaving in 2003. Mark rejoined the company in 2006 to lead UK sales and is now responsible for sales and marketing across the Group.

Mark, who holds a BA (Hons) in European Marketing from Leeds Metropolitan University and a Diploma in Sales and Marketing from the Ecole Superier de Commerce in Caen, France, has also held previous positions with CODA plc, SSA Global Technologies, Inc. and Outlooksoft, Inc.

Rod Jones, Chief Executive Officer commenting on Mark's appointment said:

"The Directors are delighted to welcome Mark to the Board. His appointment strengthens our team as we continue to deliver on our strategy to grow the business".

Mark currently holds, or has held, the following directorships:

PROACTIS Group Limited

BrandinHand Limited

Mark is beneficially interested in 3,125 Ordinary shares of 10p, representing 0.001% of the Company's issued share capital.

There are no further details required to be disclosed pursuant to Schedule Two, paragraph (g) to (viii) of the AIM Rules.

PROACTIS Holdings PLC

Rod Jones, Chief Executive Officer Tel: 019 3754 5070

www.proactis.com

Daniel Stewart & Company plc

Lindsay Mair/Tessa Smith Tel: 020 7776 6550

www.danielstewart.co.uk

Weber Shandwick Financial Tel: 020 7067 0700

Nick Oborne/John Moriarty

www.webershandwick.com

Notes to Editors:

Proactis creates, sells and maintains specialist software, which enables organisations to streamline, control and monitor all internal and external expenditure, other than payroll. PROACTIS is already used in over 200 organisations in the UK from the commercial, public and not-for-profit sectors.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAILFVAAAIAFIT
Date   Source Headline
30th Sep 20087:00 amRNSUnaudited Preliminary Results to 31 July 2008
28th Jul 20085:12 pmRNSChange of Adviser
26th Jun 20089:00 amRNSDirectorate Change
29th Apr 20083:59 pmRNSDirector/PDMR Shareholding
23rd Apr 20082:02 pmRNSInterim Results
29th Jan 20082:56 pmRNSAnnual Report and Accounts
31st Dec 20077:00 amRNSTotal Voting Rights
13th Dec 20077:01 amRNSAlito-Settlement Of Earn out
30th Oct 20077:00 amRNSFinal Results
20th Sep 20071:00 pmBUSBristol City Council Wins Achievement of Excellence Procurement Award from the National Purchasing Institute
29th Aug 200712:00 pmBUSProactis Brings Spend Control to the US
29th Aug 200712:00 pmBUSProactis Signs Global Technical and Marketing Agreement with Microsoft
17th Aug 200712:02 pmRNSChange of advisor name
17th Aug 200710:15 amRNSAIM Rule 26
8th Aug 200711:35 amRNSTrading Statement
29th Jun 20077:00 amRNSTotal Voting Rights
11th Jun 20072:46 pmRNSIssue of Equity
31st May 20077:00 amRNSTotal Voting Rights
9th May 20074:01 pmRNSChange of Registered Address
9th May 20073:55 pmRNSIssue of Equity
29th Mar 20077:00 amRNSInterim Results
29th Mar 20077:00 amRNSAcquisition
19th Feb 200712:14 pmRNSAGM Statement
19th Jan 20072:37 pmRNSAnnual Report and Accounts
19th Dec 20062:46 pmRNSTotal Voting Rights
20th Nov 20067:01 amRNSAcquisition
10th Oct 20067:00 amRNSFinal Results
1st Aug 20067:03 amRNSBusiness Update
26th Jun 20064:52 pmRNSNotifiable Interest
26th Jun 20069:38 amRNSNotifications of Interest
1st Jun 20068:01 amRNSFirst Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.